Skip to main content Accessibility help
×
Home

Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women

  • Sarah M. Bristow (a1), Greg D. Gamble (a1), Angela Stewart (a1), Lauren Horne (a1), Meaghan E. House (a1), Opetaia Aati (a1), Borislav Mihov (a1), Anne M. Horne (a1) and Ian R. Reid (a1)...

Abstract

Ca supplements are used for bone health; however, they have been associated with increased cardiovascular risk, which may relate to their acute effects on serum Ca concentrations. Microcrystalline hydroxyapatite (MCH) could affect serum Ca concentrations less than conventional Ca supplements, but its effects on bone turnover are unclear. In the present study, we compared the acute and 3-month effects of MCH with conventional Ca supplements on concentrations of serum Ca, phosphate, parathyroid hormone and bone turnover markers. We randomised 100 women (mean age 71 years) to 1 g/d of Ca as citrate or carbonate (citrate–carbonate), one of two MCH preparations, or a placebo. Blood was sampled for 8 h after the first dose, and after 3 months of daily supplementation. To determine whether the acute effects changed over time, eight participants assigned to the citrate dose repeated 8 h of blood sampling at 3 months. There were no differences between the citrate and carbonate groups, or between the two MCH groups, so their results were pooled. The citrate–carbonate dose increased ionised and total Ca concentrations for up to 8 h, and this was not diminished after 3 months. MCH increased ionised Ca concentrations less than the citrate–carbonate dose; however, it raised the concentrations of phosphate and the Ca–phosphate product. The citrate–carbonate and MCH doses produced comparable decreases in bone resorption (measured as serum C-telopeptide (CTX)) over 8 h and bone turnover (CTX and procollagen type-I N-terminal propeptide) at 3 months. These findings suggest that Ca preparations, in general, produce repeated sustained increases in serum Ca concentrations after ingestion of each dose and that Ca supplements with smaller effects on serum Ca concentrations may have equivalent efficacy in suppressing bone turnover.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: S. M. Bristow, fax +64 9 373 7677, email s.bristow@auckland.ac.nz

References

Hide All
1 Bolland, MJ, Grey, A, Gamble, GD, et al. (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94, 11441149.
2 Li, K, Kaaks, R, Linseisen, J, et al. (2012) Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98, 920925.
3 Xiao, Q, Murphy, RA, Houston, DK, et al. (2013) Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 173, 639646.
4 Iso, H, Stampfer, MJ, Manson, JE, et al. (1999) Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 30, 17721779.
5 Karp, HJ, Ketola, ME & Lamberg-Allardt, CJ (2009) Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women. Br J Nutr 102, 13411347.
6 Heaney, RP, Dowell, MS, Bierman, J, et al. (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20, 239246.
7 Karkkainen, MU, Wiersma, JW & Lamberg-Allardt, CJ (1997) Postprandial parathyroid hormone response to four calcium-rich foodstuffs. Am J Clin Nutr 65, 17261730.
8 Slinin, Y, Blackwell, T, Ishani, A, et al. (2011) Serum calcium, phosphorus and cardiovascular events in post-menopausal women. Int J Cardiol 149, 335340.
9 Jorde, R, Sundsfjord, J, Fitzgerald, P, et al. (1999) Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 34, 484490.
10 Shin, S, Kim, KJ, Chang, HJ, et al. (2012) Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 33, 28732881.
11 Reid, IR & Bolland, MJ (2012) Risk factors: calcium supplements and cardiovascular risk. Nat Rev Cardiol 9, 497498.
12 Bischoff-Ferrari, HA, Kiel, DP, Dawson-Hughes, B, et al. (2009) Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 24, 935942.
13 Warensjo, E, Byberg, L, Melhus, H, et al. (2011) Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 342, d1473.
14 Bauer, DC (2013) Clinical practice. Calcium supplements and fracture prevention. N Engl J Med 369, 15371543.
15 Manson, JE & Bassuk, SS (2014) Calcium supplements: do they help or harm? Menopause 21, 106108.
16 Ma, J, Johns, RA & Stafford, RS (2007) Americans are not meeting current calcium recommendations. Am J Clin Nutr 85, 13611366.
17 Pasco, JA, Sanders, KM, Henry, MJ, et al. (2000) Calcium intakes among Australian women: Geelong Osteoporosis Study. Aust N Z J Med 30, 2127.
18 University of Otago and Ministry of Health (2011) A Focus on Nutrition: Key Findings of the 2008/09 New Zealand Adult Nutrition Survey. Wellington: Ministry of Health.
19 Martins, I, Dantas, A, Guiomar, S, et al. (2002) Vitamin and mineral intakes in elderly. J Nutr Health Aging 6, 6365.
20 Lovelace, HY & Barr, SI (2005) Diagnosis, symptoms, and calcium intakes of individuals with self-reported lactose intolerance. J Am Coll Nutr 24, 5157.
21 Reid, IR, Schooler, BA, Hannan, SF, et al. (1986) The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med 16, 193197.
22 Tang, BM, Eslick, GD, Nowson, C, et al. (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370, 657666.
23 Angus, RM, Sambrook, PN, Pocock, NA, et al. (1989) A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 89, 209214.
24 Deroisy, R, Zartarian, M, Meurmans, L, et al. (1997) Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 16, 249253.
25 Horowitz, M, Wishart, JM, Goh, D, et al. (1994) Oral calcium suppresses biochemical markers of bone resorption in normal men. Am J Clin Nutr 60, 965968.
26 Thomas, SD, Need, AG, Tucker, G, et al. (2008) Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women. Calcif Tissue Int 83, 8184.
27 Bolland, MJ, Grey, A, Avenell, A, et al. (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342, d2040.
28 Buclin, T, Jacquet, AF & Burckhardt, P (1986) Intestinal absorption of calcium gluconate and oseine–mineral complex: an evaluation by conventional analyses. Schweiz Med Wochenschr 116, 17801783.
29 Nicar, MJ & Pak, CY (1985) Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metab 61, 391393.
30 Harvey, JA, Zobitz, MM & Pak, CY (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3, 253258.
31 Recker, RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313, 7073.
32 Heaney, RP, Recker, RR & Weaver, CM (1990) Absorbability of calcium sources: the limited role of solubility. Calcif Tissue Int 46, 300304.
33 Ekman, M, Reizenstein, P, Teigen, SW, et al. (1991) Comparative absorption of calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and chloride solution. Bone 12, 9397.
34 el-Hajj Fuleihan, G, Klerman, EB, Brown, EN, et al. (1997) The parathyroid hormone circadian rhythm is truly endogenous – a general clinical research center study. J Clin Endocrinol Metab 82, 281286.
35 Greenspan, SL, Dresner-Pollak, R, Parker, RA, et al. (1997) Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 60, 419423.
36 Wichers, M, Schmidt, E, Bidlingmaier, F, et al. (1999) Diurnal rhythm of CrossLaps in human serum. Clin Chem 45, 18581860.
37 Qvist, P, Christgau, S, Pedersen, BJ, et al. (2002) Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31, 5761.
38 Ahmad, AM, Hopkins, MT, Fraser, WD, et al. (2003) Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 32, 170179.
39 Riggs, BL, O'Fallon, WM, Muhs, J, et al. (1998) Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13, 168174.
40 Reid, IR, Mason, B, Horne, A, et al. (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119, 777785.
41 Reid, IR, Ames, R, Mason, B, et al. (2008) Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 168, 22762282.
42 Ruegsegger, P, Keller, A & Dambacher, MA (1995) Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporos Int 5, 3034.
43 Pelayo, I, Haya, J, De la Cruz, JJ, et al. (2008) Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: a randomized trial. Menopause 15, 11321138.
44 Ciria-Recasens, M, Blanch-Rubio, J, Coll-Batet, M, et al. (2011) Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study. Clin Drug Investig 31, 817824.
45 Foley, RN, Collins, AJ, Ishani, A, et al. (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156, 556563.
46 Foley, RN, Collins, AJ, Herzog, CA, et al. (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20, 397404.
47 Dhingra, R, Sullivan, LM, Fox, CS, et al. (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167, 879885.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed